Circadian Rhythms of Dopamine and Cholecystokinin in Nucleus Accumbens and Striatum of Rats—Influence on Dopaminergic Stimulation

References

• Vanderhaeghen JJ, Signeau JC, Gepts W. New peptide in the vertebrate C'NS reacting with gastrin antibodies. Nature 1975; 257: 604–5
   PubMed Web of Science ®Google Scholar
• Eysselein VE, Reeve JR, Jr, Eberlein G. Cholecystokinin-gene structure, and molecular forms in tissue and blood. Z Gastroenterol 1986; 24: 645–59
   PubMed Web of Science ®Google Scholar
• Loren I, Alumets J, Hakanson R, Sundler F. Distribution of gastrin and CCK-like peptides in the rat brain. Histochemistry 1979; 59: 249–57
   PubMedGoogle Scholar
• Hökfelt T, Rehfeld JF, Skirboll L, Ivemark B, Goldstein M, Markey K. Evidence for coexistence of dopamine and CCK in meso-limbic neurones. Nature 1980; 285: 476–7
   PubMed Web of Science ®Google Scholar
• Johansson O, Hökfelt T, Pernow B, et al. Immunohistochemical support for three putative neurotransmitters in one neuron: coexistence of 5-hydroxytryptamin-, substance P-and thyrotropin releasing hormone-like immunoreactivity in medullary raphe neurones projecting to the spinal cord. Neuroscience 1981; 6: 1857–82
   PubMed Web of Science ®Google Scholar
• Albers HE, Liou S-Y, Stopa EG, Zoeller RT. Neurotransmitter colocalization and circadian rhythms. Prog Brain Res 1992; 92: 289–306
   PubMedGoogle Scholar
• Crawley JN. Microinjection of cholecystokinin into the rat ventral tegmental area potentiates dopamine-induced hypolocomotion. Synapse 1989; 3: 346–55
   PubMedGoogle Scholar
• Hutchinson JB, Strupish J, Nahorski SR. Release of endogenous dopamine and cholecystokinin from rat striatal slices: effects of amphetamine and dopamine antagonists. Brain Res 1986; 370: 310–14
   PubMedGoogle Scholar
• Martin J, Beinfeld MC, Wang RY. Modulation of cholecystokinin release from posterior nucleus acumbens by D-2 dopamine receptor. Brain Res 1986; 397: 253–8
   PubMedGoogle Scholar
• Meyer DK, Holland A, Conzelmann U. Release of cholecystokinin-like immunoreactivity from slices of dorsal and ventral striatum of rat brain. Neurochem Int 1984; 6: 371–5
   Google Scholar
• Chronopharmacology—cellular and biochemical interactions, B. Lemmer. Marcel Dekker, New York 1989
   Google Scholar
• Kuczenski R, Segal D. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 1989; 9: 2051–65
   PubMedGoogle Scholar
• Kreutz MR, Acworth IN, Lehnert H, Wurtman RJ. Systemic administration of thyrotropin-releasing hormone enhances striatal dopamine release in vivo. Brain Res 1990; 536: 347–52
   PubMedGoogle Scholar
• Demarest KT, Lawson-Wendling KL, Moore KE. d-Amphetamine and γ-butyrolactone alteration of dopamine synthesis in the terminals of nigrostriatal and mesolimbic neurons. Biochem Pharmacol 1983; 32: 691–7
   PubMedGoogle Scholar
• Fukamauchi F, Yoshikawa T, Kaneno S, Shibuya H, Takahashi R. Dopamincrgic agents affected neuronal transmission of cholecystokinin in the rat brain. Neumpeptides 1987; 10: 207–20
   PubMedGoogle Scholar
• Murrin C, Roth R. Dopaminergic neurons: reversal of effects elicited by γ-butyrolactone by stimulation of the nigro-striatal pathway. Naunyn Schmiedebergs Arch Pharmacol 1976; 295: 15–20
   PubMedGoogle Scholar
• Sofroniew MV. Golgi-like immunoperoxidase staining of neurons producing specific substances or of neurons transporting exogeneous tracer proteins. Immunohistochemistry. IBRO-Handbook Series: methods in neurosciences, AC Cuello. Wiley, Chichester 1983; 431–47
   Google Scholar
• Schade R, Oelssner W, Göhler K, et al. Characterization of anti-CCK-8 antibodies raised in hens and rabbits by means of several in vitro and in vivo animal models. Biogenic Amines 1988; 5: 535–50
   Google Scholar
• Paxinos G, Watson C. The rat brain in slereotaxic coordinates. Academic Press, Sydney 1986
   Google Scholar
• Opacka-Juffry J, Tacconelli F, Cocn CW. Sensitive method for determination of picogram amounts of epinephrine and other catecholamines in microdissected samples of rat brain using liquid chromatography with electrochemical detection. J Chromatogr 1989; 433: 41–51
   Google Scholar
• Mattes A, Witte K, Hohmann W, Lemmer B. PHARMFIT—a nonlinear fitting program for pharmacology. Chronobiol Int 1991; 8: 460–76
   PubMed Web of Science ®Google Scholar
• Scheving L, Harrison WH, Gordon P, Pauly JE. Daily fluctuation (circadian and ultradian) in biogenic amines of the rat brain. Am J Physiol 1968; 214: 166–73
   PubMed Web of Science ®Google Scholar
• Bhasharan D, Radha E. Circadian variations in the monoamine levels and monoamine oxidase activity in different regions of the rat brain as a function of age. Exp Gerontol 1984; 19: 153–70
   PubMedGoogle Scholar
• Lemmer B, Berger T. Diurnal rhythm in the cerebral dopamine turnover in the rat. Naunyn Schmiedebergs Arch Pharmacol 1978; 303: 257–61
   PubMed Web of Science ®Google Scholar
• Nicholson SA, Adrian TE, Bacarese-Hamilton AJ, Gillham B, Jones MT, Bloom SR. 24-Hour variation in content and release of hypothalamic neuropeptides in the rat. Regul Pept 1983; 7: 385–97
   PubMedGoogle Scholar
• O'Neill MF, Dourish CT, Iversen SD. Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCK/A receptor antagonist devazepide but not the CCK/B receptor antagonist L-365,260. EurJ Pharmacol 1991; 193: 203–8
   PubMed Web of Science ®Google Scholar
• Schnur P, Espinoza M, Flores R. Effects of diurnal phase and pimozide on cholecystokinin-elicited hypoactivity in the hamster. Pharmacol Biochem Behav 1992; 43: 979–84
   PubMedGoogle Scholar
• Yoshikawa T, Fukamauchi F, Shibuya H, Takahashi R. Regional heterogeneity within the nucleus accumbens concerning the effects of dopaminergic agents on the content of cholecystokinin. Neurochem Int 1989; 14: 467–9
   PubMedGoogle Scholar
• Yoshikawa T, Fukamauchi F, Shibuya H, Takahashi R. Apomorphine affects cholecystokinin content via preferentially D1 or D2 dopamine receptor according to the regions of the rat brain. Neuropeptides 1989; 13: 103–5
   PubMedGoogle Scholar
• Chan-Palay V. Combined immunocytochemistry and autoradiography after in vivo injections of monoclonal antibody to substance P and 3H-serotonin: coexistence of two putative transmitters in single raphe cells and fiber plexuses. Anat Embryol 1979; 156: 241–54
   PubMedGoogle Scholar
• Schade R, Vick K, Sohr R, Pfister C, Lemmer B, Bellach J. Evidence for circadian time-dependent variations of two coexistent neuronal agents (CCK, dopamine) in substantia nigra and striatum of rat brain. J Interdiscipl Cycle Res 1993; 24: 241–4
   Web of Science ®Google Scholar